Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05855369 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 180 to 145v5
  2. Site contact updated Eligibility criteria expanded, about 3 words · Study title expanded, about 1 wordv4 Show 2 more changesShow less
    • Eligibility criteria expanded, about 3 words
    • Study title expanded, about 1 word

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Jan 2028 to May 31, 2028v3
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Sep 2023 to Oct 2, 2023 · Secondary endpoints: details revised at 1 of 8 entriesv2 Show 3 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 2023 to Oct 2, 2023
    • Secondary endpoints: details revised at 1 of 8 entries
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Persistent smell loss that can include diminished or distorted smell function is a common symptom of long COVID syndrome. There are limited treatment options for long COVID-related smell loss. This study aims to determine the efficacy of two at-home treatments, smell training and non-invasive trigeminal nerve stimulation. This study requires participants to conduct daily at-home treatment sessions, attend three in-person study visits at the MUSC Department of Psychiatry and Behavioral Sciences, and complete electronic questionnaires over the 12-week trial, and again at the six-month timepoint. Participants in this trial may benefit directly with an improvement in sense of smell. However, participation may also help society more generally, as this study will provide new information about long COVID-related smell loss and its treatment.
Trial Details
NCT Number NCT05855369
Lead Sponsor Medical University of South Carolina
Collaborators: National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Smell Dysfunction, Olfactory Disorder, Long COVID
Enrollment 145 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov